Literature DB >> 2605112

Collagen cross-link synthesis in cultured vascular endothelium.

C I Levene1, G Heale, S P Robins.   

Abstract

Cultured vascular endothelium secretes the enzyme lysyl oxidase which cross-links both collagen and elastin. The major reducible cross-link synthesized by cultured human umbilical arterial and venous endothelium is dihydroxylysinonorleucine (di-OH-LNL). Treatment of the cultures with the lathyrogen beta-aminopropionitrile (BAPN), which inhibits lysyl oxidase, inhibited synthesis of this cross-link. Cultured porcine aortic endothelium synthesized three major reducible lysine-derived cross-links: dihydroxylysinonorleucine (di-OH-LNL), hydroxylysinonorleucine (OH-LNL) and lysinonorleucine (LNL); BAPN also inhibited synthesis of these three cross-links. Earlier in-vivo observations on BAPN-treated chick embryos had shown a 20% increase in the hydration of cartilage and other tissues; the likeliest explanation was that cross-link disruption permitted the proteoglycans in cartilage to express their hydrophilic nature when freed of their collagenous network. Capillary basement membrane contains laminin, proteoglycan and type IV collagen. Following the finding of oedema in lathyritic cartilage, we would propose that agents which disrupt collagen cross-links in cultured vascular endothelium, damaging capillary basement membrane, be considered as one possible mechanism in the pathogenesis of oedema.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2605112      PMCID: PMC2040723     

Source DB:  PubMed          Journal:  Br J Exp Pathol        ISSN: 0007-1021


  15 in total

1.  The production of lysyl oxidase by human fibroblasts in culture.

Authors:  D L Layman; A S Narayanan; G R Martin
Journal:  Arch Biochem Biophys       Date:  1972-03       Impact factor: 4.013

2.  On the inhibition of lysyl oxidase by -aminopropionitrile.

Authors:  A S Narayanan; R C Siegel; G R Martin
Journal:  Biochem Biophys Res Commun       Date:  1972-01-31       Impact factor: 3.575

3.  The cross-linking of collagen and elastin: enzymatic conversion of lysine in peptide linkage to alpha-aminoadipic-delta-semialdehyde (allysine) by an extract from bone.

Authors:  S R Pinnell; G R Martin
Journal:  Proc Natl Acad Sci U S A       Date:  1968-10       Impact factor: 11.205

Review 4.  Cross-linking in collagen and elastin.

Authors:  D R Eyre; M A Paz; P M Gallop
Journal:  Annu Rev Biochem       Date:  1984       Impact factor: 23.643

Review 5.  Analysis of the crosslinking components in collagen and elastin.

Authors:  S P Robins
Journal:  Methods Biochem Anal       Date:  1982

6.  Phenotypic changes in morphology and collagen polymorphism of cultured bovine and porcine aortic endothelium.

Authors:  C I Levene; C Bartlet; G Heale
Journal:  Atherosclerosis       Date:  1984-07       Impact factor: 5.162

7.  Structure and function of basement membrane.

Authors:  J R Stanley; D T Woodley; S I Katz; G R Martin
Journal:  J Invest Dermatol       Date:  1982-07       Impact factor: 8.551

8.  Synthesis of interstitial collagens by pig aortic endothelial cells in culture.

Authors:  M J Barnes; L F Morton; C I Levene
Journal:  Biochem Biophys Res Commun       Date:  1978-10-16       Impact factor: 3.575

Review 9.  Posttranslational protein modifications, with special attention to collagen and elastin.

Authors:  P M Gallop; M A Paz
Journal:  Physiol Rev       Date:  1975-07       Impact factor: 37.312

10.  Alterations in state of molecular aggregation of collagen induced in chick embryos by beta-aminopropionitrile (lathyrus factor).

Authors:  C I LEVENE; J GROSS
Journal:  J Exp Med       Date:  1959-11-01       Impact factor: 14.307

View more
  1 in total

1.  The lysyl oxidase inhibitor, beta-aminopropionitrile, diminishes the metastatic colonization potential of circulating breast cancer cells.

Authors:  Alla Bondareva; Charlene M Downey; Fabio Ayres; Wei Liu; Steven K Boyd; Benedikt Hallgrimsson; Frank R Jirik
Journal:  PLoS One       Date:  2009-05-19       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.